Rapid Biomarker Profiling Clinically Available
The first AI-powered biomarker profiling test to identify actionable alterations in NSCLC patients
LungOI can support making timely and informed clinical decisions
Rapid identification of lung cancer biomarkers from the biopsy image or glass slide.
Multi-gene NSCLC biomarker profiling panel providing next-day test results.
A Laboratory Developed Test through a CLIA certified and CAP accredited laboratory
Test-specific code and reimbursement rate for Medicare & Medicaid Services (CMS).
Simplifying and Accelerating Detection of NSCLC Actionable Biomarkers
Time
Rapid analysis reducing turnaround time from weeks to minutes
Tissue
Utilizing the diagnostic slide with no need for dedicated tissue
Access
A laboratory developed test available through a certified CLIA lab
Submit a case process
Operated with Lumea
HIPAA compliant,
secured LIS
or send an H&E
glass slide
Upload directly
to our secured LIS
Rapid AI-based
biomarker profiling
Next day report
available online
LungOI can help you make timely and informed clinical decisions
Operated with Lumea
HIPAA compliant,
secured LIS
or send an H&E
glass slide
Upload directly
to our secured LIS
Rapid AI-based
biomarker profiling
Next day report
available online
The science behind LungOI
Foundation Model Development
The LungOI model was developed leveraging our state-of-the-art digital pathology foundation model achieving high performance for profiling NSCLC biomarkers.
High-Volume Training
Using our foundation model, we processed and trained thousands of biopsy images to detect a comprehensive panel of lung cancer-related genes.
Validated Precision
LungOI was validated using an external dataset from over 10 medical centers and further confirmed in a single-center prospective study, ensuring robustness and accuracy.
Clinical Accessibility
The LungOI Lab Developed Test is processed in a CLIA-certified, CAP-accredited lab, ensuring that it meets high standards for clinical use and compliance.
The science behind LungOI
Foundation Model Development
The LungOI model was developed leveraging our state-of-the-art digital pathology foundation model achieving high performance for profiling NSCLC biomarkers.
High-Volume Training
Using our foundation model, we processed and trained thousands of biopsy images to detect a comprehensive panel of lung cancer-related genes.
Validated Precision
LungOI was validated using an external dataset from over 10 medical centers and further confirmed in a single-center prospective study, ensuring robustness and accuracy.
Clinical Accessibility
The LungOI Lab Developed Test is processed in a CLIA-certified, CAP-accredited lab, ensuring that it meets high standards for clinical use and compliance.
Patient Story
- Patient: Woman, age 40
- Diagnosis: Metastatic to brain NSCLC adenocarcinoma
- Planned treatment: Tumor board required rapid treatment, with whole neuroaxis RT considered while waiting for CGP Imagene’s AI algorithm deployed and inferred an EGFR mutation. Subsequent rapid PCR test confirmed EGFR L858R mutation Treatment initiated within 2 days from the biopsy, averting the need for brain radiation.
- Outcome: MRI scans after 2 months showed complete response in all sites
FAQs
Who is the test intendent for?
This test is designed to support clinicians in managing patients diagnosed with NSCLC (Non-Small Cell Lung Cancer).
How to order a test?
A clinician who is interested in submitting a case for the LungOI NSCLC Biomarker Profiling Test, should follow these steps:
- Send a request email to lab@imagene-ai.com.
- Include your name, work email address, and phone number in the email.
- Our team will contact you to register an account for the online lab portal.
- You will receive secured log-in details and a scheduled onboarding call, where we will guide you through the process of submitting a case.
This streamlined process ensures you can get started quickly and easily.
Can a patient order the test?
No, ordering the LungOI NSCLC Biomarker Profiling Test is limited to clinicians. Patients cannot order the test directly.
How long does it take to receive the test results?
LungOI delivers next-day test results, ensuring a fast and efficient turnaround time. The test report will be available on the LungOI online lab portal, and the clinician will receive a notification email once the results are ready.